TECX Stock Analysis: Buy, Sell, or Hold?
TECX - Tectonic Therapeutic, Inc. Common Stock
$37.93
5.19 (15.85%)
▲
5d:
+22.24%
30d:
+38.28%
90d:
+23.23%
WAIT
LOW Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When TECX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: TECX is 16.5% above its trading range ($32.56). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: TECX is 16.5% above its trading range ($32.56). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: TECX is currently trading at $37.93, which is considered extended relative to its 30-day fair value range of $28.32 to $32.56.
Technical Outlook: Technically, TECX is in a uptrend. The price is approaching resistance at $36.48. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 15.9% recently.
Market Sentiment: TECX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $78.44 (+106.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TECX is in a uptrend. The price is approaching resistance at $36.48. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 15.9% recently.
Market Sentiment: TECX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $78.44 (+106.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$28.32 -
$32.56
Company Quality Score
64/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BEARISH: Price significantly overextended (+16.5% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+15.9%)
- BULLISH: Trading 106.8% below Wall St target ($78.44)
- WARNING: Recommendation downgraded due to 16.5% overvaluation
Trading Range Analysis
30-Day Trading Range
$28.32 -
$32.56
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$29.27
Resistance Level
$36.48
Current Trend
Uptrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-6.68
Wall Street Target
$78.44
(+106.8%)
Share & Embed Analysis
Last updated: July 02, 2026 10:48 PM ET
Data refreshes hourly during market hours. Next update: 11:48 PM
Data refreshes hourly during market hours. Next update: 11:48 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TECX showing a specific setup today?
Insider Activity (6 Months)
1
Buys
5
Sells
Net
INSIDERS SELLING
Recent Transactions
Marcella K Ruddy
SELL
1000 shares
2026-04-01
Marcella K Ruddy
SELL
10000 shares
2026-03-06
Peter Mcnamara
SELL
6262 shares
2026-03-06
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 55 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$833 | 63 BUY |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 54 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 63 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
